A 52-year-old man with seropositive RA (RF+, anti-CCP+) on methotrexate 25 mg/week for 8 weeks presents with persistent active disease: DAS28 score 5.8, tender joint count 14, swollen joint count 12, ESR 55 mm/h. He has tolerated methotrexate well with normal LFTs and FBC. What is the most appropriate next step in management?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.